- Home
- WIX vs CORT Comparison
WIX vs CORT Comparison
Compare WIX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIX
- CORT
- Stock Information
- Founded
- WIX 2006
- CORT 1998
- Country
- WIX Israel
- CORT United States
- Employees
- WIX N/A
- CORT N/A
- Industry
- WIX Computer Software: Programming Data Processing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- WIX Technology
- CORT Health Care
- Exchange
- WIX Nasdaq
- CORT Nasdaq
- Market Cap
- WIX 8.8B
- CORT 7.5B
- IPO Year
- WIX 2013
- CORT N/A
- Fundamental
- Price
- WIX $155.05
- CORT $70.86
- Analyst Decision
- WIX Strong Buy
- CORT Strong Buy
- Analyst Count
- WIX 18
- CORT 4
- Target Price
- WIX $226.94
- CORT $142.00
- AVG Volume (30 Days)
- WIX 689.3K
- CORT 1.5M
- Earning Date
- WIX 08-06-2025
- CORT 07-28-2025
- Dividend Yield
- WIX N/A
- CORT N/A
- EPS Growth
- WIX 119.71
- CORT 8.36
- EPS
- WIX 2.51
- CORT 1.14
- Revenue
- WIX $1,814,525,000.00
- CORT $685,446,000.00
- Revenue This Year
- WIX $13.99
- CORT $35.85
- Revenue Next Year
- WIX $12.81
- CORT $35.22
- P/E Ratio
- WIX $61.52
- CORT $62.03
- Revenue Growth
- WIX 12.89
- CORT 30.93
- 52 Week Low
- WIX $137.94
- CORT $32.33
- 52 Week High
- WIX $247.11
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- WIX 47.03
- CORT 47.37
- Support Level
- WIX $145.64
- CORT $70.14
- Resistance Level
- WIX $156.46
- CORT $73.78
- Average True Range (ATR)
- WIX 4.88
- CORT 2.48
- MACD
- WIX -0.52
- CORT 0.09
- Stochastic Oscillator
- WIX 43.01
- CORT 59.70
About WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.